TCF4 and breast neoplasm: Thus, it would be of great interest and importance to investigate whether TBLR1 upregulates C-erbB-2 expression via β-catenin/TCF4 transcription complex or others, and whether knocking down of TBLR1 could reduce the tumorigencity of C-erbB-2-overexpressing breast tumors.